Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand.
about
Kindlin-2 regulates podocyte adhesion and fibronectin matrix deposition through interactions with phosphoinositides and integrinsCooperation between integrin alphavbeta3 and VEGFR2 in angiogenesisMegakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling.A specific interface between integrin transmembrane helices and affinity for ligandActivation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignmentA computational analysis of the dynamic roles of talin, Dok1, and PIPKI for integrin activationThe oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alpha(v)beta3 integrins.Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasisThe CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.Matrix-specific suppression of integrin activation in shear stress signaling.Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signalingIntegrin-mediated adhesion regulates membrane orderUltrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells.Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.Quantitative analysis of platelet alpha v beta 3 binding to osteopontin using laser tweezers.Multi-step fibrinogen binding to the integrin (alpha)IIb(beta)3 detected using force spectroscopy.Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent.Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets.Acidic extracellular pH promotes activation of integrin α(v)β(3).Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasionalpha(v)beta(3) Integrin antagonists as inhibitors of bone resorption.Integrin activation controls metastasis in human breast cancerModulation of integrin activation by an entropic spring in the {beta}-kneeDynamic adhesion of umbilical cord blood endothelial progenitor cells under laminar shear stress.Molecular pathway for cancer metastasis to bone.Mechanisms contributing to the activity of integrins on leukocytes.Interaction of kindlin-2 with integrin β3 promotes outside-in signaling responses by the αVβ3 vitronectin receptorActivated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cellsUltrasmall integrin-targeted silica nanoparticles modulate signaling events and cellular processes in a concentration-dependent manner.Integrin-targeted imaging of inflammation in vascular remodelingIntegrin β3 inhibition is a therapeutic strategy for supravalvular aortic stenosis.CIB1 is an endogenous inhibitor of agonist-induced integrin alphaIIbbeta3 activation.Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransductionIntegrin signaling is critical for pathological angiogenesisActivation of alpha(v)beta3-vitronectin binding is a multistage process in which increases in bond strength are dependent on Y747 and Y759 in the cytoplasmic domain of beta3.The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells.Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.General in vivo assay for the study of integrin cell membrane receptor microclustering.Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.
P2860
Q24293222-1E0D5DB0-0C9A-4CDE-980E-03E407153072Q24318607-83A9CC0B-EF87-4D83-8BA8-B67CDB329576Q24538576-AEC4512E-5A45-401C-A709-EAB749E19536Q24793060-CC2BAB83-6D57-43A4-9EB9-2A84896B6435Q28348367-9AD4E393-68D4-4802-A748-416B99FA1AB5Q28477989-AD2F7C2A-2D6A-4EE2-9924-65D90363A257Q28567964-E674950F-B493-4C5A-8678-0C52FD20B74AQ28770073-21454A63-E49A-4ED6-B841-B518BBBEDF9DQ30441368-5EF4AE2A-DBB4-4D17-812C-18B100402124Q30441401-62FFC95A-E395-4D4F-B51B-ED4A8F7605DDQ30442042-B2ECD8F5-B3CB-4E7E-A347-5B81824801BBQ30444200-2215F8D4-976A-4249-926A-89A467D53F94Q30493883-787097F8-E804-41A9-8C32-9DE1D3E4EE94Q31074551-894C0B48-4206-4D6E-9CA8-62FA662D00E6Q33193773-E8DA612F-2BC6-403D-AF93-9CF3D6352061Q33220247-B74F5234-519C-4515-903F-0597D05FCA03Q33546368-4496554D-87D3-43A5-B747-691DAD532AD8Q33610587-9F28E578-6BF4-42F5-9983-4C31942B74C4Q33809484-EC6072A9-45DA-488F-90F8-D8FEB4DF6641Q33872298-3014FA72-313D-4CEE-BDAB-0A2AE1048C96Q33892041-FC59F44F-0EB2-4B1C-9B09-33EF33340105Q34074902-FE90F4DD-CCC1-4741-B8DE-D1719E4AF702Q34107054-706205F0-8F88-4470-9D0E-DD24DF9AE46CQ34236673-D6B07220-7285-426D-B5B7-D10CFE3860FDQ34388631-AF760356-8595-4F4F-9FA2-1C4C6A39B6E1Q34600581-3774A5EB-A9B7-4485-9D8F-F46333FE175BQ34862279-26C8834D-4C91-4666-B3F0-AFBD0D3AD374Q35197456-BE5CB535-5B27-42EF-9B90-6EBA69392158Q35234791-4B130AF2-EFA0-4EFA-AF92-738269A5C60AQ35562019-9A245114-20C7-40F9-9F2B-1524ECE4B41EQ35586045-91C55E56-E1AC-493E-A7AA-CBE8B68DFD30Q35917857-C56355F4-EDA3-4F24-8CCF-7F769F819B6BQ36116790-A8052DC0-0A3B-4663-A7B4-6F98563AE489Q36149399-E2DCDBD6-CD93-4FA5-9155-CC3F5A26CD0BQ36228035-6D76D48E-68A1-4271-9D22-27D725E2651CQ36278857-7A183ABB-E51C-46F5-8BCA-3C64E7C46AC3Q36322653-E0F2FCD5-43F2-4381-8764-4437DA0C1430Q36324236-2A295846-62E0-4830-B307-10CEA7984F9BQ36883258-3A0A514A-11E8-4256-B423-E56191EDC552Q37234281-6629C44B-6611-4561-A1FF-CF22D05FE848
P2860
Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Mechanisms and consequences of ...... -engineered monovalent ligand.
@en
type
label
Mechanisms and consequences of ...... -engineered monovalent ligand.
@en
prefLabel
Mechanisms and consequences of ...... -engineered monovalent ligand.
@en
P2093
P2860
P356
P1476
Mechanisms and consequences of ...... -engineered monovalent ligand.
@en
P2093
Cheresh DA
Nemerow GR
Shattil SJ
Stupack DG
P2860
P304
21609-21616
P356
10.1074/JBC.274.31.21609
P407
P577
1999-07-01T00:00:00Z